HKSE - Delayed Quote HKD
INNOVENT BIO (1801.HK)
51.450
-1.000
(-1.91%)
At close: April 23 at 4:08:49 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
147,810
147,810
-1,918,804
-2,024,843
-307,688
Investing Cash Flow
-998,662
-998,662
-1,435,185
-2,698,148
-5,184,588
Financing Cash Flow
2,587,257
2,587,257
2,892,082
5,003,361
4,912,121
End Cash Position
2,745,693
2,745,693
1,016,165
1,359,408
1,276,178
Capital Expenditure
-1,383,460
-1,383,460
-1,381,730
-1,847,516
-771,778
Issuance of Capital Stock
2,255,116
2,255,116
2,131,059
3,950,520
4,662,363
Issuance of Debt
1,335,549
1,335,549
1,080,172
1,463,083
372,178
Repayment of Debt
-917,050
-917,050
-365,000
-255,000
-17,000
Free Cash Flow
-1,235,650
-1,235,650
-3,300,534
-3,872,359
-1,079,466
12/31/2020 - 10/31/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6160.HK BeiGene, Ltd.
151.500
+1.34%
9926.HK Akeso, Inc.
92.900
+5.09%
9688.HK Zai Lab Limited
26.000
+6.56%
2269.HK WuXi Biologics (Cayman) Inc.
22.700
+5.34%
1530.HK 3SBIO
12.800
+2.24%
9966.HK Alphamab Oncology
7.320
+5.17%
2142.HK HBM Holdings Limited
7.850
-3.21%
9969.HK InnoCare Pharma Limited
10.360
-1.33%
1952.HK Everest Medicines Limited
49.700
+1.84%
1177.HK SINO BIOPHARM
3.840
+0.26%